Billionaire Buys Stake In Gene Therapy Stock
Ultragenyx may not have crossed your radar but it’s already in billionaire Stan Druckenmiller’s portfolio. What has he spotted in this novel therapies for rare and ultra-rare genetic diseases firm that convinced him to take a position?
Its focus on underserved patient populations, deep pipeline of innovative products, and strong track record in obtaining regulatory approvals make it an attractive long-term investment, » Read more about: Billionaire Buys Stake In Gene Therapy Stock »
Read More
1 Spectacular SaaS Stock Taking Over the Planet
Amid the recent bear market, many renowned stocks have dipped to bargain prices, with analysts advocating for big names like Apple and Amazon. But, what about the lesser-known gems?
In the data industry, Planet Labs is shining bright. After reading this article, you may want to consider adding this Earth-imaging company to your portfolio of growth opportunities.
» Read more about: 1 Spectacular SaaS Stock Taking Over the Planet »
Read More
84.2% of Bill Gates Portfolio In 4 Stocks
If you went to an Ivy League business school, you would probably learn about diversification and efficient markets, and how it’s not possible to beat the market. Why then do so many billionaires violate the tenets of top academics?
In simple terms, when you have an information advantage, or a winning investment thesis,
» Read more about: 84.2% of Bill Gates Portfolio In 4 Stocks »
Read More
3 Stunning Buffett Stocks Set To Soar
Stoneco (STNE) is a leading provider of payment solutions for e-commerce businesses and merchants in Latin America.
In Q3, the company reported revenue of approximately $390 million and EBIT of nearly $33 million.
The platform has attracted over 2.3 million SMBs yet the stock has seen a significant decline of over 40% this year as political challenges in Brazil and a rising interest rate environment acted as headwinds.
» Read more about: 3 Stunning Buffett Stocks Set To Soar »
Read More
1 Rare Stock Buffett Is Buying
Warren Buffett has spent 2024 stockpiling cash, even going so far as to sell off sizeable pieces of some of his largest investments. Recently, though, Berkshire Hathaway announced that it had made some modest acquisitions, including the addition of nearly 388,000 shares of domain name registry service Verisign (NASDAQ:VRSN).
These purchases brought Berkshire Hathaway’s holdings in Verisign to 13.2 million shares,
» Read more about: 1 Rare Stock Buffett Is Buying »
Read MoreThe Ivy
Wall Street’s Favorite Sleeper in the AI Infrastructure Boom?
Data streaming might sound like a back-office technology, the kind of thing only engineers care about, but it’s quickly becoming a foundational pillar of the digital world. And while most investors are busy chasing flashy AI stocks, one lesser-known name sits quietly at the heart of this infrastructure shift, Confluent (NASDAQ: CFLT).
» Read more about: Wall Street’s Favorite Sleeper in the AI Infrastructure Boom? »
Read MoreThe Spotlight
Spotlight: Unicorn Stock Is Envy of Fintech
Earlier in the week we covered a stock that had both impressive revenue growth and a handsome dividend, a rare combination that is hard to find in any industry. The stock was United Healthcare and it had a ten year history of growing year-over-year revenues in each quarter.
That inspired us to find other companies that are also growing yet pay a handsome dividend.
» Read more about: Spotlight: Unicorn Stock Is Envy of Fintech »
Read MoreThe Daily
Travis Kelce hints at retirement plans on ‘New Heights’
(NewsNation) — Travis Kelce has dropped hints about retiring from the NFL after the Kansas City Chiefs failed to make the playoffs this season.
Travis Kelce was on his “New Heights” podcast with his brother Jason Kelce talking about what’s next as he looks ahead to the next season.
» Read more about: Travis Kelce hints at retirement plans on ‘New Heights’ »